A concurrent resolution urging Japan to honor its commitments under the 1986 Market-Oriented Sector-Selective (MOSS) Agreement on Medical Equipment and Pharmaceuticals, and for other purposes.

Summary

Urges Japan to honor its commitments under the Market-Oriented Sector-Selective (MOSS) Agreement on Medical Equipment and Pharmaceuticals by: (1) reducing regulatory barriers to the approval and adoption of new medical technologies; (2) establishing reasonable agency performance goals for premarket approvals and an appropriate, risk-based postmarket system consistent with globally accepted practices; (3) actively promoting pricing policies that encourage innovation; (4) implementing fair and open processes and rules that do not disproportionately harm United States medical technology products; and (5) providing opportunities for consultation with trading partners.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 10 November 2003

   Introduced

   Read twice and referred to the Committee on Foreign Relations. (text of measure as introduced: CR S14364)

   Source: IntroReferral

2. 10 November 2003

   Introduced

   Introduced in Senate

   Source: IntroReferral

Votes

No vote records are attached yet.

Versions

• Introduced in Senate · 10 November 2003 · Official file

Documents

3 official files

• Introduced in Senate (text)

  Introduced in Senate · EN · 10 November 2003

  ViewDownloadOpen at official source

• Introduced in Senate (PDF)

  Introduced in Senate · EN · 10 November 2003

  ViewDownloadOpen at official source

• Introduced in Senate

  summary · EN · 10 November 2003

  Open at official source

Sponsors

• Sen. Coleman, Norm [R-MN] · R · Sponsor
• Sen. Bayh, Evan [D-IN] · D · Sponsor
• Rep. Gregg, Judd [R-NH-2] · R · Cosponsor
• Sen. Santorum, Rick [R-PA] · R · Cosponsor
• · ssfr00 · Standing

Related records

• related to → Urging Japan to honor its commitments under the 1986 Market-Oriented Sector-Selective (MOSS) Agreement on Medical Equipment and Pharmaceuticals, and for other purposes.